Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot Study: Hyaluronic Acid Filler Injection Techniques to Achieve Facial Balance in Asian Patients.

Plastic and reconstructive surgery. Global open·2025
Same author

Facial Skin Quality Improvement After Treatment With CPM-HA20G: Clinical Experience in Korea.

Journal of cosmetic dermatology·2025
Same author

Recommendations on Ultrasound-Guided Hyaluronic Acid Soft Tissue Augmentation of the Upper Face in Asians.

Journal of cosmetic dermatology·2024
Same author

Knowledge and the behavioral patterns of photoprotection among Koreans with skin disease.

Photodermatology, photoimmunology & photomedicine·2024
Same author

Tightening and Reduction of Unwanted Submental Fat Using Triple-Layer High-Intensity Focused Ultrasound: Clinical and 3-Dimensional Imaging Analysis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2021
Same author

Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study.

Acta dermato-venereologica·2020

Related Experiment Video

Updated: Jun 12, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy.

Jae Yoon Jung1, Kkot Bora Yeom, Hee Chul Eun

  • 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.

Annals of Dermatology
|June 16, 2010
PubMed
Summary

Chemical leukoderma, caused by chemical exposure, presents challenges in diagnosis and treatment. Systemic steroid pulse therapy shows promise for treating this condition, offering a potential new treatment option.

Keywords:
Chemical leukodermaSystemic steroidVitiligo

Related Experiment Videos

Last Updated: Jun 12, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Area of Science:

  • Dermatology
  • Toxicology
  • Pathology

Background:

  • Chemical leukoderma results from toxic chemical exposure, affecting melanocytes.
  • Distinguishing chemical leukoderma from vitiligo clinicohistopathologically is challenging.
  • Diagnosis relies on a history of exposure to depigmenting agents.

Observation:

  • A case report of a 51-year-old man with hypopigmented lesions after occupational chemical exposure.
  • Lesions were unresponsive to topical corticosteroids.
  • Significant improvement was observed after systemic steroid pulse therapy.

Findings:

  • Systemic steroid pulse therapy demonstrated efficacy in treating chemical leukoderma.
  • The patient experienced marked improvement in depigmented macules and patches.
  • This suggests a potential treatment avenue for recalcitrant cases.

Implications:

  • Systemic steroid pulse therapy may be a viable treatment option for chemical leukoderma.
  • Further research is warranted to establish treatment guidelines.
  • Understanding the mechanism of melanocyte damage is crucial for developing targeted therapies.